OSW-1 is a potent anticancer agent that has shown significant potential in targeting various cancer cells. It works by disrupting the function of mitochondria, leading to the induction of apoptosis in cancer cells. This mechanism makes it particularly effective against drug-resistant cancers, offering a promising avenue for treatment where conventional therapies fail. Additionally, OSW-1 has been studied for its ability to inhibit tumor growth in preclinical models, demonstrating high selectivity for cancer cells while sparing normal cells. Its unique mode of action and strong efficacy have sparked interest in further research and development as a potential therapeutic agent in oncology.